Literature DB >> 27423915

Membrane fusion during poxvirus entry.

Bernard Moss1.   

Abstract

Poxviruses comprise a large family of enveloped DNA viruses that infect vertebrates and invertebrates. Poxviruses, unlike most DNA viruses, replicate in the cytoplasm and encode enzymes and other proteins that enable entry, gene expression, genome replication, virion assembly and resistance to host defenses. Entry of vaccinia virus, the prototype member of the family, can occur at the plasma membrane or following endocytosis. Whereas many viruses encode one or two proteins for attachment and membrane fusion, vaccinia virus encodes four proteins for attachment and eleven more for membrane fusion and core entry. The entry-fusion proteins are conserved in all poxviruses and form a complex, known as the Entry Fusion Complex (EFC), which is embedded in the membrane of the mature virion. An additional membrane that encloses the mature virion and is discarded prior to entry is present on an extracellular form of the virus. The EFC is held together by multiple interactions that depend on nine of the eleven proteins. The entry process can be divided into attachment, hemifusion and core entry. All eleven EFC proteins are required for core entry and at least eight for hemifusion. To mediate fusion the virus particle is activated by low pH, which removes one or more fusion repressors that interact with EFC components. Additional EFC-interacting fusion repressors insert into cell membranes and prevent secondary infection. The absence of detailed structural information, except for two attachment proteins and one EFC protein, is delaying efforts to determine the fusion mechanism. Published by Elsevier Ltd.

Entities:  

Keywords:  Endocytosis; Hemifusion; Membrane fusion; Vaccinia virus; Virus entry

Mesh:

Substances:

Year:  2016        PMID: 27423915      PMCID: PMC5161597          DOI: 10.1016/j.semcdb.2016.07.015

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  93 in total

1.  Protein composition of the vaccinia virus mature virion.

Authors:  Wolfgang Resch; Kim K Hixson; Ronald J Moore; Mary S Lipton; Bernard Moss
Journal:  Virology       Date:  2006-09-26       Impact factor: 3.616

2.  Vaccinia virus A21 virion membrane protein is required for cell entry and fusion.

Authors:  Alan C Townsley; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails.

Authors:  B M Ward; B Moss
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components.

Authors:  Jason P Laliberte; Andrea S Weisberg; Bernard Moss
Journal:  PLoS Pathog       Date:  2011-12-15       Impact factor: 6.823

5.  Interaction between the G3 and L5 proteins of the vaccinia virus entry-fusion complex.

Authors:  Cindy L Wolfe; Bernard Moss
Journal:  Virology       Date:  2011-02-04       Impact factor: 3.616

6.  A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies.

Authors:  E J Wolffe; S Vijaya; B Moss
Journal:  Virology       Date:  1995-08-01       Impact factor: 3.616

7.  Role of the vaccinia virus O3 protein in cell entry can be fulfilled by its Sequence flexible transmembrane domain.

Authors:  P S Satheshkumar; James Chavre; Bernard Moss
Journal:  Virology       Date:  2013-06-29       Impact factor: 3.616

8.  Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment.

Authors:  G Hiller; K Weber
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

9.  Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans.

Authors:  Gemma C Carter; Mansun Law; Michael Hollinshead; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2005-05       Impact factor: 3.891

10.  Vaccinia extracellular virions enter cells by macropinocytosis and acid-activated membrane rupture.

Authors:  Florian Ingo Schmidt; Christopher Karl Ernst Bleck; Ari Helenius; Jason Mercer
Journal:  EMBO J       Date:  2011-07-26       Impact factor: 11.598

View more
  23 in total

1.  Investigating Viruses during the Transformation of Molecular Biology.

Authors:  Bernard Moss
Journal:  J Biol Chem       Date:  2017-01-30       Impact factor: 5.157

2.  The atlastin membrane anchor forms an intramembrane hairpin that does not span the phospholipid bilayer.

Authors:  Miguel A Betancourt-Solis; Tanvi Desai; James A McNew
Journal:  J Biol Chem       Date:  2018-10-04       Impact factor: 5.157

Review 3.  African Swine Fever Virus Gets Undressed: New Insights on the Entry Pathway.

Authors:  Germán Andrés
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

4.  Cell-surface phosphatidylserine regulates osteoclast precursor fusion.

Authors:  Santosh K Verma; Evgenia Leikina; Kamran Melikov; Claudia Gebert; Vardit Kram; Marian F Young; Berna Uygur; Leonid V Chernomordik
Journal:  J Biol Chem       Date:  2017-11-03       Impact factor: 5.157

5.  Deletion of the Vaccinia Virus I2 Protein Interrupts Virion Morphogenesis, Leading to Retention of the Scaffold Protein and Mislocalization of Membrane-Associated Entry Proteins.

Authors:  Seong-In Hyun; Andrea Weisberg; Bernard Moss
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

6.  Differential Innate Immune Signaling in Macrophages by Wild-Type Vaccinia Mature Virus and a Mutant Virus with a Deletion of the A26 Protein.

Authors:  Siti Khadijah Kasani; Huei-Yin Cheng; Kun-Hai Yeh; Shu-Jung Chang; Paul Wei-Che Hsu; Shu-Yun Tung; Chung-Tiang Liang; Wen Chang
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

7.  Synthesis of d-(+)-camphor-based N-acylhydrazones and their antiviral activity.

Authors:  Kseniya S Kovaleva; Fedor I Zubkov; Nikolay I Bormotov; Roman A Novikov; Pavel V Dorovatovskii; Victor N Khrustalev; Yuriy V Gatilov; Vladimir V Zarubaev; Olga I Yarovaya; Larisa N Shishkina; Nariman F Salakhutdinov
Journal:  Medchemcomm       Date:  2018-10-26       Impact factor: 3.597

8.  Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment.

Authors:  Motomu Nakatake; Nozomi Kuwano; Emi Kaitsurumaru; Hajime Kurosaki; Takafumi Nakamura
Journal:  Mol Ther       Date:  2020-12-19       Impact factor: 11.454

Review 9.  Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines.

Authors:  Felix A Rey; Shee-Mei Lok
Journal:  Cell       Date:  2018-03-08       Impact factor: 41.582

Review 10.  A comparative review of viral entry and attachment during large and giant dsDNA virus infections.

Authors:  Haitham Sobhy
Journal:  Arch Virol       Date:  2017-09-02       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.